Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation
about
An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactionsLeukocyte Ig-Like Receptors - A Model for MHC Class I Disease AssociationsHLA-dependent tumour development: a role for tumour associate macrophages?Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptorDistinct Conformations of Ly49 Natural Killer Cell Receptors Mediate MHC Class I Recognition in Trans and CisSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsPaired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells.Expression and function of Allergin-1 on human primary mast cellsDifferential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells.LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains.The interaction with H-2D(d) in cis is associated with a conformational change in the Ly49A NK cell receptor.Cis interactions of immunoreceptors with MHC and non-MHC ligands.Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells.PIR-B-deficient mice are susceptible to Salmonella infectionContrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity.Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells.Structural basis for recognition of cellular and viral ligands by NK cell receptors.Role of PIR-B in autoimmune glomerulonephritis.Cis-trans interactions of cell surface receptors: biological roles and structural basis.A novel post-transcriptional role for ubiquitin in the differential regulation of MHC class I allotypes.Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease.Surveillance of cell and tissue perturbation by receptors in the LRC.Selection, tuning, and adaptation in mouse NK cell education.Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.Cis association of leukocyte Ig-like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18.LILRB receptor-mediated regulation of myeloid cell maturation and function.Modulation of natural killer cell functions by interactions between 2B4 and CD48 in cis and in trans.HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.Regulation of immune and neural function via leukocyte Ig-like receptors.KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.Hematopoietic stem cells: interplay with immunity.The amphibians Xenopus laevis and Silurana tropicalis possess a family of activating KIR-related Immunoglobulin-like receptors.Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.Major histocompatibility complex class I molecules modulate embryonic neuritogenesis and neuronal polarization.Autoimmune arthritis induces paired immunoglobulin-like receptor B expression on CD4+ T cells from SKG mice.
P2860
Q24317225-CA0F4902-4800-43FA-9226-74604AE29C89Q26738439-B604059A-564F-455D-923A-2D55983ACBA3Q27022124-9B1ABD0A-9D54-4759-8736-F8336C682E9CQ27651216-64056531-982A-408D-9F64-00FADFAA600AQ27657738-F089B1E2-1907-4027-BE64-07E75D8219BAQ34055580-0D970354-E034-47EA-8536-428684020EAEQ34723007-00EE1695-BDAB-4A55-9737-CFA1C4885440Q35014606-D6DD3204-338B-40EE-80FC-8B3A641EB2D5Q35111055-D7FC791C-DBA4-4951-935E-90B3B5A75A3BQ35112707-05DD6FD4-D26E-4196-9FEC-D46839117390Q35670468-AB8C7981-9305-4118-BD49-DA024F8FF9BDQ35927588-92790E0B-D2E4-4312-9A8D-3E3DA9F91707Q36800512-7D8F3FEB-521D-41F0-BAFE-18194D2CCC63Q36871415-AC49AFA7-7283-4682-8146-5FBD0323DB9FQ37036889-5B2F5A5F-4288-4735-ACE8-95DAD242907FQ37070759-4D0DF20D-756A-43AF-B1E3-E5780DBEA07DQ37331550-23E06435-ECBC-427C-9DAD-2D73A559201AQ37445098-FE62E5FD-ABD1-4B56-B11B-1F97AB147338Q37678862-A6F29F5D-DFCB-4FB2-9D8B-559DB9E1F728Q37803135-B7B4D249-29C6-4160-8AFF-432CF7C5863CQ37921661-CCB2ADE0-55D1-48B3-A59F-44CB6B1500D2Q38058915-26F678F6-5F73-47E7-9463-1E4FD8DD1CF6Q38377860-B8E3AEB5-08C7-486B-9139-47643E6FF071Q38568867-7DFAF69D-105A-4C74-AB98-4EFA1B954C25Q38568877-9B2799CA-5C79-4F43-BF54-16F2A171A7ABQ38659065-5DE8581F-914A-42F5-A62A-E92AF6588CDFQ39205013-EA462572-BD8C-4605-9466-3EC97C4E3A10Q39389817-9102F670-2755-483D-A5CF-ED8F292EDCA5Q39718472-EF89CD65-9B19-4A4D-AE47-9A80F13C1C10Q39739585-C93ED1FC-832B-4906-B715-EB92ACBF5142Q40045293-7262250D-3416-4D8B-9477-DEAC161D31B9Q40122626-F89EB602-D8C4-4BC3-85E4-B33416EDCA03Q42379841-B119343A-C62F-4F97-9975-CEA556C7CB68Q42926776-2D5470F5-9DE1-4B0B-A4FE-A5C985A8237EQ44843573-34F2EFF8-95CB-4C0C-908A-66CF102E860CQ46230267-801F8F09-9926-4A09-8F44-7B219965BA3BQ50915395-D744CF2F-7138-4BB1-A46D-93B255A5442F
P2860
Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cis binding between inhibitory ...... regulate mast cell activation
@ast
Cis binding between inhibitory ...... regulate mast cell activation
@en
type
label
Cis binding between inhibitory ...... regulate mast cell activation
@ast
Cis binding between inhibitory ...... regulate mast cell activation
@en
prefLabel
Cis binding between inhibitory ...... regulate mast cell activation
@ast
Cis binding between inhibitory ...... regulate mast cell activation
@en
P2093
P2860
P356
P1476
Cis binding between inhibitory ...... regulate mast cell activation
@en
P2093
Akira Nakamura
Toshiyuki Takai
Tsutomu Maeda
Yuzuru Sakamoto
P2860
P304
P356
10.1084/JEM.20060631
P407
P577
2007-04-09T00:00:00Z